Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Clinical Transplantation|May 25, 2013
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donorsMats Remberger, Olle Ringdén, Hans Hägglund, et al.
Plos One|March 9, 2023
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host diseaseIgor Novitzky-Basso, Frida Schain, Nurgul Batyrbekova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignanciesKatarina Le Blanc, A John Barrett, Marie Schaffer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 12, 2025
Prospective Double-Blind Randomized Study of Single Dose Bone Marrow-Derived Mesenchymal Stromal Cells versus Placebo for Steroid-Refractory Acute Graft-Versus-Host DiseaseOlle Ringdén, Guido Moll, Britt Gustafsson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 1, 2014
The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipientsKarin Garming Legert, Georgios Tsilingaridis, Mats Remberger, et al.
Clinical Transplantation|March 16, 2019
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant diseasePetter Svenberg, Tengyu Wang, Michael Uhlin, et al.
Transplantation|October 14, 2006
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioningMehmet Uzunel, Mats Remberger, Darius Sairafi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2013
Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioningEmma Watz, Mats Remberger, Olle Ringden, et al.
Pageof 18